Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1 1

Status

Recruiting 2Completed 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Lymphoma 447Precursor Cell Lymphoblastic Leukemia-Lymphoma 413Lymphoma, Large B-Cell, Diffuse 348Lymphoma, Non-Hodgkin 317Leukemia, Lymphocytic, Chronic, B-Cell 286Leukemia 260Lymphoma, Follicular 241Burkitt Lymphoma 217Lymphoma, Mantle-Cell 202Hodgkin Disease 193Leukemia, Myeloid, Acute 190Myelodysplastic Syndromes 172Lymphoma, B-Cell, Marginal Zone 142Multiple Myeloma 116Lymphoma, Large-Cell, Immunoblastic 116Lymphoma, B-Cell 103Recurrence 100Leukemia, Myelogenous, Chronic, BCR-ABL Positive 76Myeloproliferative Disorders 75Leukemia, Myeloid, Chronic-Phase 73Dendritic Cell Sarcoma, Interdigitating 73Leukemia, Myeloid, Accelerated Phase 72Leukemia, Myelomonocytic, Chronic 67Lymphoma, Large-Cell, Anaplastic 65Waldenstrom Macroglobulinemia 63Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 63Neoplasms, Plasma Cell 59Blast Crisis 58Primary Myelofibrosis 54Congenital Abnormalities 52

Interventions

Rituximab 4Doxorubicin 3Cyclophosphamide 3Vincristine 2Prednisone 2Etoposide 2pomalidomide 1merphos 1fludarabine 1brincidofovir 1Zidovudine 1Tomography, X-Ray Computed 1Polymerase Chain Reaction 1Nivolumab 1Methotrexate 1Leucovorin 1Interferons 1In Situ Hybridization 1Immunohistochemistry 1Hydroxyurea 1Flow Cytometry 1Echocardiography 1EPOCH protocol 1Cytogenetic Analysis 1Caves 1Brentuximab Vedotin 1Blotting, Western 1AP 1903 reagent 13-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Epstein-Barr Virus Infections × Cyclophosphamide × Lymphoid × Clear all
NCT05389423 2026-06-01

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
25 enrolled
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Epstein-Barr Virus Infections

NCT00001379 2025-06-19

Treatment and Natural History Study of Lymphomatoid Granulomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
94 enrolled 20 charts
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Lymphomatoid Granulomatosis, Lymphoproliferative Disorders, Epstein-Barr Virus Infections

NCT06224049 2024-03-12

GI-hNeoT-01

BGI, China

Phase EARLY_PHASE1 Recruiting
6 enrolled
Lymphoid

Lymphoma, T-Cell, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡